XML 24 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Assets    
Loans receivable, net of deferred origination and other fees $ 60,218,841 $ 65,405,731
Interest and other fees receivable on loans 1,642,825 1,521,033
Cash 204,889 178,012
Cash – restricted 23,350 23,750
Other assets 60,742 62,080
Right-of-use asset – operating lease, net 101,226 154,039
Deferred financing costs, net 98,858 16,171
Total assets 62,350,731 67,360,816
Liabilities:    
Lines of credit 17,601,132 16,427,874
Senior secured notes (net of deferred financing costs of $96,985) 5,903,015
Accounts payable and accrued expenses 173,247 232,236
Operating lease liability 112,076 167,119
Loan holdback 50,000 50,000
Dividends payable 1,314,732 1,315,445
Total liabilities 19,251,187 24,095,689
Stockholders’ equity:    
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,432,451 and 11,438,651 outstanding, respectively 11,757 11,757
Additional paid-in capital 45,575,006 45,561,941
Less: Treasury shares, at cost – 324,607 and 318,407 shares, respectively (1,098,964) (1,070,406)
Accumulated deficit (1,388,255) (1,238,165)
Total stockholders’ equity 43,099,544 43,265,127
Total liabilities and stockholders’ equity $ 62,350,731 $ 67,360,816